- Home
- SGHT vs AOMR Comparison
SGHT vs AOMR Comparison
Compare SGHT & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- AOMR
- Stock Information
- Founded
- SGHT 2011
- AOMR 2018
- Country
- SGHT United States
- AOMR United States
- Employees
- SGHT N/A
- AOMR N/A
- Industry
- SGHT Medical Specialities
- AOMR Real Estate Investment Trusts
- Sector
- SGHT Health Care
- AOMR Real Estate
- Exchange
- SGHT Nasdaq
- AOMR Nasdaq
- Market Cap
- SGHT 193.2M
- AOMR 224.3M
- IPO Year
- SGHT 2021
- AOMR 2021
- Fundamental
- Price
- SGHT $3.45
- AOMR $9.36
- Analyst Decision
- SGHT Buy
- AOMR Strong Buy
- Analyst Count
- SGHT 8
- AOMR 6
- Target Price
- SGHT $4.21
- AOMR $11.25
- AVG Volume (30 Days)
- SGHT 103.2K
- AOMR 110.8K
- Earning Date
- SGHT 11-06-2025
- AOMR 11-05-2025
- Dividend Yield
- SGHT N/A
- AOMR 13.73%
- EPS Growth
- SGHT N/A
- AOMR N/A
- EPS
- SGHT N/A
- AOMR 1.56
- Revenue
- SGHT $76,303,000.00
- AOMR $57,661,000.00
- Revenue This Year
- SGHT N/A
- AOMR N/A
- Revenue Next Year
- SGHT $12.04
- AOMR $12.91
- P/E Ratio
- SGHT N/A
- AOMR $5.96
- Revenue Growth
- SGHT N/A
- AOMR N/A
- 52 Week Low
- SGHT $2.03
- AOMR $7.36
- 52 Week High
- SGHT $6.29
- AOMR $10.88
- Technical
- Relative Strength Index (RSI)
- SGHT 42.70
- AOMR 39.73
- Support Level
- SGHT $3.20
- AOMR $9.29
- Resistance Level
- SGHT $3.43
- AOMR $9.60
- Average True Range (ATR)
- SGHT 0.14
- AOMR 0.13
- MACD
- SGHT -0.00
- AOMR -0.03
- Stochastic Oscillator
- SGHT 46.79
- AOMR 7.27
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.